Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor.
José Carlos Jaime-PérezMónica Andrea Pinzón-UrestiRaúl Alberto Jiménez-CastilloJulia Esther Colunga-PedrazaÓscar González-LlanoGuillermo José Ruiz ArgüellesPublished in: Hematology (Amsterdam, Netherlands) (2017)
A high rate of very early, CNS, and BM relapse with a considerably low 5-year OS requiring reassessment of therapy was documented. Organomegaly at diagnosis was a highly significant clinical predictor for relapse.